Skip To Main Content
Qiuying Gu on Muck Rack

Qiuying Gu

As seen in: Nature, Biomed Central (BMC), Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Qiuying

Contact Qiuying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer

|
By Chunyan Tang, Qiuying Gu, Qingya Luo, Xin Luo Luo, Fatao Luo, Tao Liu, Ping Yi, Linlu Cui, Qihua Yi
| Nature Verified
Abstract Ovarian cancer remains a leading cause of gynecologic cancer mortality, largely due to high recurrence and frequent cisplatin resistance. This study investigates the role of ADAR1 lactylation-mediated RNA editing in ovarian cancer chemoresistance. Cisplatin-resistant cells exhibit significantly elevated global adenosine-to-inosine (A-to-I) RNA editing and ADAR1 expression.
Open in Who Shared Issue with article?

Prognostic value of Ki67 in epithelial ovarian cancer

|
By Yuexi Liu, Qiuying Gu, Yao Xiao, Xing Wei
| Dove Medical Press
Back to Journals » Cancer Management and Research » Volume 16 Authors Liu Y, Gu Q , Xiao Y, Wei X, Wang J, Huang X, Linghu H Received 15 March 2024 Accepted for publication 20 June 2024 Published 9 July 2024 Volume 2024:16 Pages 761—769 DOI https://doi.org/10.2147/CMAR.S469132 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Chien-Feng Li Yuexi Liu,* Qiuying Gu,* Yao Xiao, Xing Wei, Jinlong Wang, Xiaolan...
Open in Who Shared Issue with article?
See all 2 articles